Literature DB >> 26559019

Associating liver partition and portal vein ligation (ALPPS): Taking a view of trails.

Takeshi Takamoto1, Yasuhiko Sugawara, Takuya Hashimoto, Masatoshi Makuuchi.   

Abstract

Associating liver partition and portal vein ligation (ALPPS) is introduced as a modified two-staged hepatectomy for advanced liver malignancies, which requires extended hepatectomy with very small future remnant liver volume. It is characterized by rapid and large growth of future remnant liver and potential of widening the indication of curative resection with extended major hepatectomy for liver malignancies. It showed, however, much higher morbidity and mortality than extended hepatectomy after portal vein embolization. Here, we review the literatures and examine the role of ALPPS in Japan, where zero mortality after hepatectomy is highly expected.

Entities:  

Mesh:

Year:  2015        PMID: 26559019     DOI: 10.5582/bst.2015.01131

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  3 in total

1.  Rescue associating liver partition and portal vein ligation for staged hepatectomy after portal embolization: Our experience and literature review.

Authors:  Charlotte Maulat; Antoine Philis; Bérénice Charriere; Fatima-Zohra Mokrane; Rosine Guimbaud; Philippe Otal; Bertrand Suc; Fabrice Muscari
Journal:  World J Clin Oncol       Date:  2017-08-10

Review 2.  An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence.

Authors:  Yu-Long Cai; Pei-Pei Song; Wei Tang; Nan-Sheng Cheng
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

3.  The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS.

Authors:  Noemi Daradics; Pim B Olthof; Andras Budai; Michal Heger; Thomas M van Gulik; Andras Fulop; Attila Szijarto
Journal:  Curr Oncol       Date:  2021-12-09       Impact factor: 3.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.